|
Real-time Estimate
Cboe BZX
07:07:12 11/06/2026 pm IST
|
5-day change
|
1st Jan Change
|
|
409.66 USD
|
-0.57%
|
|
+1.16%
|
-27.25%
|
|
02/06 |
Deutsche Bank Adjusts Intuitive Surgical PT to $366 From $440, Maintains Sell Rating
|
MT
| |
27/05 |
Goldman Sachs Adjusts Price Target on Intuitive Surgical to $558 From $621, Maintains Buy Rating
|
MT
| |
22/04 |
HSBC Adjusts Price Target on Intuitive Surgical to $604 From $653, Maintains Buy Rating
|
MT
| |
22/04 |
Barclays Cuts Price Target on Intuitive Surgical to $651 From $712, Maintains Overweight Rating
|
MT
| |
22/04 |
TD Cowen Adjusts Price Target on Intuitive Surgical to $585 From $660, Maintains Buy Rating
|
MT
| |
22/04 |
Piper Sandler Adjusts Price Target on Intuitive Surgical to $580 From $620, Maintains Overweight Rating
|
MT
| |
22/04 |
JPMorgan Adjusts Price Target on Intuitive Surgical to $550 From $625, Maintains Overweight Rating
|
MT
| |
22/04 |
Leerink Partners Adjusts Price Target on Intuitive Surgical to $573 From $622, Maintains Outperform Rating
|
MT
| |
22/04 |
Raymond James Adjusts Price Target on Intuitive Surgical to $577 From $615, Maintains Outperform Rating
|
MT
| |
22/04 |
Baird Adjusts Intuitive Surgical Price Target to $610 From $575, Maintains Outperform Rating
|
MT
| |
22/04 |
Jefferies Adjusts Intuitive Surgical Price Target to $515 From $560, Maintains Hold Rating
|
MT
| |
22/04 |
Goldman Sachs Adjusts Intuitive Surgical Price Target to $621 From $609, Maintains Buy Rating
|
MT
| |
15/04 |
Baird Adjusts Intuitive Surgical Price Target to $575 From $645, Maintains Outperform Rating
|
MT
| |
15/04 |
Truist Lowers Price Target on Intuitive Surgical to $580 From $650, Keeps Buy Rating
|
MT
| |
13/04 |
Mizuho Adjusts Price Target on Intuitive Surgical to $525 From $575, Maintains Neutral Rating
|
MT
| |
13/04 |
BTIG Research Adjusts Intuitive Surgical Price Target to $574 From $616, Maintains Buy Rating
|
MT
| |
08/04 |
Goldman Sachs Adjusts Price Target on Intuitive Surgical to $609 From $714, Maintains Buy Rating
|
MT
| |
06/04 |
Evercore ISI Adjusts PT on Intuitive Surgical to $480 From $550, Maintains In Line Rating
|
MT
| |
11/03 |
Citigroup Upgrades Intuitive Surgical to Buy From Neutral, Price Target is $590
|
MT
| |
24/02 |
UBS Adjusts Price Target on Intuitive Surgical to $570 From $600, Maintains Neutral Rating
|
MT
| |
05/02 |
Argus Adjusts Price Target on Intuitive Surgical to $560 From $630, Maintains Buy Rating
|
MT
| |
27/01 |
TD Cowen Initiates Coverage on Intuitive Surgical With Buy Rating, $660 Price Target
|
MT
| |
26/01 |
HSBC Adjusts Price Target on Intuitive Surgical to $653 From $644, Maintains Buy Rating
|
MT
| |
23/01 |
China Merchants Initiates Intuitive Surgical at Buy With $613 Price Target
|
MT
| |
23/01 |
Piper Sandler Adjusts Price Target on Intuitive Surgical to $620 From $610, Maintains Overweight Rating
|
MT
|
No results match your criteria
Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
|